The carcinogenic effects of radioiodine therapy for thyroid carcinoma-Reference-Cited by-同舟云学术

The carcinogenic effects of radioiodine therapy for thyroid carcinoma

Published:2008-02-19 Issue:4 Volume:4 Page:180-181
ISSN:1745-8366
Container-title:Nature Clinical Practice Endocrinology & Metabolism
language:en
Short-container-title:Nat Rev Endocrinol

Author:

de Vathaire Florent

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.nature.com/articles/ncpendmet0761.pdf

Reference10 articles.

1. Schlumberger MJ (1998) Papillary and follicular thyroid carcinoma. N Engl J Med 338: 297–306

2. Kolbert KS et al. (2007) Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software. J Nucl Med 48: 143–149

3. Sandeep TC et al. (2006) Second primary cancers in thyroid cancer patients: a multinational record linkage study. J Clin Endocrinol. Metab 91: 1819–1825

4. Rubino C et al. (2003) Second primary malignancies in thyroid cancer patients. Br J Cancer 89: 1638–1644

5. Berthe E et al. (2004) Risk of second primary cancer following differentiated thyroid cancer. Eur J Nucl Med Mol Imaging 31: 685–691

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidentally Detected Metachronous Malignancy in Patients of Papillary Carcinoma of Thyroid Posthigh-Dose Radioiodine Therapy;Indian Journal of Nuclear Medicine;2023

2. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022

3. Radionuclide Therapy of Thyroid Tumors;Nuclear Oncology;2022

4. Prognostic factors and the effect of radioiodine on patients with locally advanced differentiated thyroid cancer;Annals of Translational Medicine;2020-08

5. Second primary cancers in pediatric head and neck cancer survivors in Denmark during 1980–2014: A nationwide study;International Journal of Pediatric Otorhinolaryngology;2019-12